These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 38287764

  • 1. Serum and urine galactose deficient-IgA1 as alternative biomarkers in the management of IgA nephropathy.
    Suleman AA, Abd Ghani F, Fadhlina NZ, Rafidah H.
    Med J Malaysia; 2024 Jan; 79(1):95-101. PubMed ID: 38287764
    [Abstract] [Full Text] [Related]

  • 2. Serum levels of galactose-deficient IgA are elevated in patients with IgA nephropathy but do not correlate to disease activity or progression.
    Elíasdóttir S, Khramova A, Saeed A, Guron G, Boi R, Mölne J, Ebefors K, Nyström J.
    BMC Nephrol; 2023 Jun 07; 24(1):160. PubMed ID: 37286948
    [Abstract] [Full Text] [Related]

  • 3. A panel of serum biomarkers differentiates IgA nephropathy from other renal diseases.
    Yanagawa H, Suzuki H, Suzuki Y, Kiryluk K, Gharavi AG, Matsuoka K, Makita Y, Julian BA, Novak J, Tomino Y.
    PLoS One; 2014 Jun 07; 9(5):e98081. PubMed ID: 24858067
    [Abstract] [Full Text] [Related]

  • 4. Galactose-Deficient IgA1 as a Candidate Urinary Polypeptide Marker of IgA Nephropathy?
    Suzuki H, Allegri L, Suzuki Y, Hall S, Moldoveanu Z, Wyatt RJ, Novak J, Julian BA.
    Dis Markers; 2016 Jun 07; 2016():7806438. PubMed ID: 27647947
    [Abstract] [Full Text] [Related]

  • 5. Serum galactose-deficient immunoglobulin A1 in recurrent immunoglobulin a nephropathy after kidney transplantation: A meta-analysis.
    Gong Z, Tang J, Hu W, Song X, Liu X, Mu J, Su Y.
    Transpl Immunol; 2023 Aug 07; 79():101850. PubMed ID: 37182720
    [Abstract] [Full Text] [Related]

  • 6. Significance of serum galactose deficient IgA1 as a potential biomarker for IgA nephropathy: A case control study.
    Bagchi S, Lingaiah R, Mani K, Barwad A, Singh G, Balooni V, Bhowmik D, Agarwal SK.
    PLoS One; 2019 Aug 07; 14(3):e0214256. PubMed ID: 30917188
    [Abstract] [Full Text] [Related]

  • 7. Clinical significance of serum and mesangial galactose-deficient IgA1 in patients with IgA nephropathy.
    Wada Y, Matsumoto K, Suzuki T, Saito T, Kanazawa N, Tachibana S, Iseri K, Sugiyama M, Iyoda M, Shibata T.
    PLoS One; 2018 Aug 07; 13(11):e0206865. PubMed ID: 30388165
    [Abstract] [Full Text] [Related]

  • 8. Clinical Significance of Serum Galactose-Deficient IgA1 Level in Children with IgA Nephropathy.
    Irabu H, Shimizu M, Kaneko S, Inoue N, Mizuta M, Ohta K, Yachie A.
    J Immunol Res; 2020 Aug 07; 2020():4284379. PubMed ID: 32537466
    [Abstract] [Full Text] [Related]

  • 9. Immunostaining of galactose-deficient IgA1 by KM55 is not specific for immunoglobulin A nephropathy.
    Zhao L, Peng L, Yang D, Chen S, Lan Z, Zhu X, Yuan S, Chen G, Liu Y, Liu H.
    Clin Immunol; 2020 Aug 07; 217():108483. PubMed ID: 32479989
    [Abstract] [Full Text] [Related]

  • 10. Biomarkers for IgA nephropathy on the basis of multi-hit pathogenesis.
    Suzuki H.
    Clin Exp Nephrol; 2019 Jan 07; 23(1):26-31. PubMed ID: 29740706
    [Abstract] [Full Text] [Related]

  • 11. Diagnostic and prognostic value of galactose-deficient IgA1 in patients with IgA nephropathy: an updated systematic review with meta-analysis.
    Zeng Q, Wang WR, Li YH, Liang Y, Wang XH, Yan L, Yu RH.
    Front Immunol; 2023 Jan 07; 14():1209394. PubMed ID: 37671165
    [Abstract] [Full Text] [Related]

  • 12. Novel lectin-independent approach to detect galactose-deficient IgA1 in IgA nephropathy.
    Yasutake J, Suzuki Y, Suzuki H, Hiura N, Yanagawa H, Makita Y, Kaneko E, Tomino Y.
    Nephrol Dial Transplant; 2015 Aug 07; 30(8):1315-21. PubMed ID: 26109484
    [Abstract] [Full Text] [Related]

  • 13. Clinical Significance of Galactose-Deficient IgA1 by KM55 in Patients with IgA Nephropathy.
    Zhang K, Li Q, Zhang Y, Shang W, Wei L, Li H, Gao S, Yan T, Jia J, Liu Y, Lin S.
    Kidney Blood Press Res; 2019 Aug 07; 44(5):1196-1206. PubMed ID: 31574506
    [Abstract] [Full Text] [Related]

  • 14. Specific immune biomarker monitoring in two children with severe IgA nephropathy and successful therapy with immunoadsorption in a rapidly progressive case.
    Cambier A, Dossier C, Hogan J, Baudouin V, Maisin A, Couderc A, Kwon T, Gleeson PJ, Monteiro RC.
    Pediatr Nephrol; 2022 Jul 07; 37(7):1597-1603. PubMed ID: 34997322
    [Abstract] [Full Text] [Related]

  • 15. A Novel Biomarker for Post-Transplant Recurrent IgA Nephropathy.
    Temurhan S, Akgul SU, Caliskan Y, Artan AS, Kekik C, Yazici H, Demir E, Caliskan B, Turkmen A, Oguz FS, Sever MS.
    Transplant Proc; 2017 Apr 07; 49(3):541-545. PubMed ID: 28340830
    [Abstract] [Full Text] [Related]

  • 16. Galactose-deficient IgA1 in African Americans with IgA nephropathy: serum levels and heritability.
    Hastings MC, Moldoveanu Z, Julian BA, Novak J, Sanders JT, McGlothan KR, Gharavi AG, Wyatt RJ.
    Clin J Am Soc Nephrol; 2010 Nov 07; 5(11):2069-74. PubMed ID: 20634323
    [Abstract] [Full Text] [Related]

  • 17. Galactose-deficient IgA1 and the corresponding IgG autoantibodies predict IgA nephropathy progression.
    Maixnerova D, Ling C, Hall S, Reily C, Brown R, Neprasova M, Suchanek M, Honsova E, Zima T, Novak J, Tesar V.
    PLoS One; 2019 Nov 07; 14(2):e0212254. PubMed ID: 30794576
    [Abstract] [Full Text] [Related]

  • 18. Galactose-Deficient IgA1 B cells in the Circulation of IgA Nephropathy Patients Carry Preferentially Lambda Light Chains and Mucosal Homing Receptors.
    Zachova K, Jemelkova J, Kosztyu P, Ohyama Y, Takahashi K, Zadrazil J, Orsag J, Matousovic K, Galuszkova D, Petejova N, Mestecky J, Raska M.
    J Am Soc Nephrol; 2022 May 07; 33(5):908-917. PubMed ID: 35115327
    [Abstract] [Full Text] [Related]

  • 19. IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis.
    Suzuki H, Yasutake J, Makita Y, Tanbo Y, Yamasaki K, Sofue T, Kano T, Suzuki Y.
    Kidney Int; 2018 Mar 07; 93(3):700-705. PubMed ID: 29329643
    [Abstract] [Full Text] [Related]

  • 20. Aberrant IgA1 Glycosylation in IgA Nephropathy: A Systematic Review.
    Sun Q, Zhang Z, Zhang H, Liu X.
    PLoS One; 2016 Mar 07; 11(11):e0166700. PubMed ID: 27870872
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.